The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...
Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback